exploratory endpoints

Related by string. * Exploratory : exploratory wildcat prospect . exploratory arthroscopic surgery . exploratory wells . Rudy Giuliani Presidential Exploratory . exploratory drilling / EndPoint . Endpoints . Endpoint : primary efficacy endpoint . Secondary endpoints include . secondary efficacy endpoints . video conferencing endpoints . Secondary endpoints included * *

Related by context. Frequent words. (Click for all words.) 69 secondary efficacy endpoints 67 Secondary endpoints 65 somatic symptoms 63 Negative Syndrome 62 HRQOL 61 COPD exacerbations 61 myocardial perfusion 61 secondary endpoints 61 multivariate analyzes 61 vasomotor symptoms 61 myocardial ischemia 61 placebo controlled studies 61 subgroup analyzes 60 Secondary endpoints include 60 C Reactive Protein 60 HSCT 60 fasting insulin 60 haematological 60 Ischemic 60 Secondary endpoints included 60 cardiometabolic risk 60 immunohistochemical 60 renal toxicity 60 Thrombolysis 60 laboratory abnormalities 60 concomitant medications 60 fasting plasma glucose 60 PREZISTA r 59 confounding variables 59 Pioglitazone 59 virologic response 59 tolvaptan 59 cardiac dysfunction 59 apolipoprotein B 59 pharmacokinetic profiles 59 composite endpoint 59 elevated triglycerides 59 Main Outcome Measures 59 therapeutic regimens 59 cardiovascular morbidity 59 RCTs 59 thromboembolic 59 comorbid conditions 59 efficacy endpoint 59 symptom severity 59 mRNA expression 59 LUTS 59 serum calcium 59 T2DM 59 platelet activation 58 lipid profiles 58 histologic 58 GFT# 58 clinical endpoints 58 subscales 58 secondary endpoint 58 Celecoxib 58 ADAS cog 58 efficacy endpoints 58 NLX P# 58 lipid lowering therapy 58 glycemia 58 Postoperative 58 neuropathies 58 hyperglycaemia 58 Pharmacokinetic 58 HRQoL 58 neuropathological 58 Immunogenicity 58 achieved statistical significance 58 irbesartan 58 Unified Parkinson Disease 58 univariate 58 histopathological 58 hypoglycemic events 58 retinal thickness 58 neuropsychiatric symptoms 57 surrogate endpoint 57 Atopic Dermatitis 57 infarct size 57 pharmacodynamic effects 57 pharmacodynamic 57 covariates 57 antihypertensive agents 57 angiotensin converting enzyme inhibitors 57 mycophenolate mofetil 57 fasting glucose levels 57 fluoxetine Prozac 57 prognostic factors 57 serum uric acid 57 Traficet EN 57 NHANES III 57 albuminuria 57 Solid Tumors 57 lymphopenia 57 echocardiographic 57 lamotrigine 57 patients evaluable 57 QoL 57 liver transplant recipients 57 cystatin C

Back to home page